QA: Cyclo Therapeutics Inc in us_chemicals/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000922247_2017_Cyclo_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Ignoring company because Liabilities is zero pre-agg {'balance_sheet': {'company_id': '0000922247', 'EntityCommonStockSharesOutstanding': 73105834, 'Assets': 2088648, 'AssetsCurrent': 1895784, 'AssetsNoncurrent': 0, 'CostOfRevenue': 132918, 'Expenses': 5081077, 'IntangibleAssets': 0, 'Liabilities': 0, 'LiabilitiesAndStockholdersEquity': 2088648, 'LiabilitiesCurrent': 0, 'LiabilitiesNoncurrent': 0, 'NetIncome': -3833060, 'PropertyPlantAndEquipmentNet': 25736, 'Revenues': 1237756, 'SellingGeneralAndAdministrativeExpense': 2292892, 'remainder_Assets': 167128, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 2655267, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 2088648, 'remainder_NetIncome': 10261, 'remainder_Revenues': 1237756, 'obs_EconomicCapitalRatio': nan}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000922247')"}

Graph

Absolute values for 0000922247, Cyclo Therapeutics Inc

  xvar xval
0 LiabilitiesCurrent 342,542
1 LiabilitiesNoncurrent 0
2 remainder_Liabilities 0
3 AssetsCurrent 1,635,533
4 PropertyPlantAndEquipmentNet 29,984
5 IntangibleAssets 0
6 AssetsNoncurrent 203,028
7 remainder_Assets 0
8 CostOfRevenue 198,429
9 SellingGeneralAndAdministrativeExpense 1,864,726
10 remainder_Expenses 3,645,640
11 remainder_Revenues 1,502,908
12 remainder_NetIncome -17,954
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Liabilities 342,542
1 Assets 1,868,545
2 Expenses 5,708,795
3 Revenues 1,502,908
4 StockholdersEquity 1,526,003
5 NetIncome -4,223,841
6 ComprehensiveNetIncome -4,223,841
7 BaseVar 4,720,372
8 EconomicCapitalRatiobeforeLimitedLiability -2.70
9 EconomicCapitalRatio 0.0880

Edgar->Model Mapping

Feature Distribution

Change over Time